Back
Phathom Pharmaceuticals Vs. Braze Industry Stock Comparison
Buy
67
PHAT
Phathom Pharmaceuticals
Last Price:
9.19
Seasonality Move:
-5.3%
Sell
28
BRZE
Braze
Last Price:
41.72
Seasonality Move:
13.84%
Buy
67
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $9.18. The Score for PHAT is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Braze (BRZE)
is a Sell
Is Braze a Buy, Sell or Hold?
- The current Braze [BRZE] share price is $41.71. The Score for BRZE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- BRZE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $9.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing slight selling pressure.
BRZE Stock Price Chart
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 43.31 | Sell |
| Chaikin Money Flow: | -23658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.35 - 11.07) | Sell |
| Bollinger Bands (100): | (7.48 - 10.2) | Buy |
BRZE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.29 | Sell |
| Relative Strength Index (14 RSI): | 40.72 | Sell |
| Chaikin Money Flow: | 1306 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.47 - 46.81) | Sell |
| Bollinger Bands (100): | (45.85 - 57.29) | Sell |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.22 | Sell |
| 20-day SMA: | 10.08 | Sell |
| 50-day SMA: | 9.78 | Sell |
| 200-day SMA: | 10.14 | Sell |
| 8-day EMA: | 9.33 | Sell |
| 20-day EMA: | 9.69 | Sell |
| 50-day EMA: | 9.52 | Sell |
| 200-day EMA: | 9.71 | Sell |
BRZE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.31 | Buy |
| 20-day SMA: | 41.54 | Buy |
| 50-day SMA: | 48.93 | Sell |
| 200-day SMA: | 48.54 | Sell |
| 8-day EMA: | 40.98 | Buy |
| 20-day EMA: | 42.54 | Sell |
| 50-day EMA: | 46.68 | Sell |
| 200-day EMA: | 47.36 | Sell |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.75 per share, and an increase next year of $1.24 per share.
Braze Earnings Growth & BRZE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.03 per share, an increase this year of $0.42 per share, and an increase next year of $0.18 per share.
Phathom Pharmaceuticals Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Braze Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||